NCT01469416View on ClinicalTrials.gov

Drug Interaction Study of Clopidogrel and Rosuvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Healthy
Interventions
DRUG

Rosuvastatin

Rosuvastatin 20 mg PO x 1

DRUG

Clopidogrel

Clopidogrel 300 mg PO x 1 (30 minutes prior to rosuvastatin dose); Clopidogrel 75 mg PO x 1 (24 hours post-rosuvastatin dose)

Trial Locations (1)

94143

Clinical Research Center, UCSF, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT01469416 - Drug Interaction Study of Clopidogrel and Rosuvastatin | Biotech Hunter | Biotech Hunter